The Success of Ovulation Induction with Letrozole and Gonadotropins in Obese and Nonobese Women: A Study from a Tertiary Center
Background. Letrozole, an aromatase inhibitor, is suggested as a first-line drug for ovulation induction in women with polycystic ovary syndrome (PCOS) especially in obese women. Letrozole has also been used in women with unexplained infertility with similar rates of success to clomiphene. However,...
Saved in:
Main Authors: | Vaidyanathan Gowri (Author), Arwa Al-Amri (Author), Thikra Mohammed Abdulrahman Almamari (Author), Maha Al Khaduri (Author), Sanjay Jaju (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current evidence supporting "letrozole" for ovulation induction
by: Sujata Kar
Published: (2013) -
Comparing the effect of gonadotropin versus letrozole for induction of ovulation in patients with polycystic ovary syndrome with clomiphene citrate failure
by: Ahmed I.A Ali, et al.
Published: (2022) -
Induction of ovulation with letrozole in women with polycystic ovary syndrome
by: G E Chernukha, et al.
Published: (2017) -
Lessons from low-dose gonadotropin therapy for ovulation induction in polycystic ovary syndrome: Can prolonged letrozole therapy eliminate failure to respond to oral ovulation agents?
by: Richard J. Paulson, M.D., M.S
Published: (2023) -
Letrozole 2.5 mg Shows Higher Endometrial Thickness Compared to 5 mg Letrozole in Ovulation Induction
by: Anita Tobing
Published: (2012)